RT Journal Article
SR Electronic
T1 Unified Predictive Model for Endometriosis: Merging Clinical, Self-reporting and Genetic Information
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.20.22272657
DO 10.1101/2022.03.20.22272657
A1 Blass, Ido
A1 Sahar, Tali
A1 Shraibman, Adi
A1 Ofer, Dan
A1 Rappoport, Nadav
A1 Linial, Michal
YR 2022
UL http://medrxiv.org/content/early/2022/03/21/2022.03.20.22272657.abstract
AB Endometriosis is a condition characterized by implants of endometrial tissues into extrauterine sites, mostly within the pelvic peritoneum. The prevalence of endometriosis is under-diagnosed, and estimated to account for 5–10% of all women of reproductive age. The goal of this study is to develop a model for endometriosis based on the UK-biobank (UKBB). We partitioned the data into those diagnosed with endometriosis (5,924; ICD-10: N80) and a control group (142,576). We included over 1000 variables from UKBB covering personal information about female health, lifestyle, self-reported data, genetic variants, and medical history prior to endometriosis diagnosis. We applied machine learning algorithms to train an endometriosis prediction model. The optimal prediction was achieved with the gradient boosting algorithms of CatBoost for the data-combined model, with an area under the ROC curve (roc-AUC) of 0.78. We discovered that, prior to being diagnosed with endometriosis, women had significantly more ICD-10 diagnoses than the average unaffected woman. Informative features, ranked by SHAP values included irritable bowel syndrome (IBS) and the length of the menstrual cycle. We conclude that the rich population-based retrospective data from the UKBB is valuable for developing predictive models despite the limitations of missing data and noisy medical input. The informative features of the model may improve clinical utility for endometriosis diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the ISF grant number: 2753/20 (to M.L.). The Louise and Alan Edwards Foundation, Clinical Research Fellowship Grant 2021 (to T.S.)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesModel based on the UK-Biobank(AI)Artificial intelligence(AUC)Area under the ROC Curve(DL)Deep Learning(EHR)Electronic Health Records(OT)OpenTargets(ROC)Receiver Operating Characteristic Curve(IBS)Irritable bowel syndrome(UKBB)UK-Biobank(PRS)Polygenic risk score(T2D)Type 2 diabetes(BMI)Body mass index